Inventor
Thomas Ryll
Inventor
San Mateo, CA, US
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes21%
C07KPeptides18%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture18%
C01GCompounds containing metals not covered by subclasses c01d or c01f9%
C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds9%
H01MProcesses or means, e.g. batteries, for the direct conversion of chemical energy into electrical energy9%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution9%
A61KPreparations for medical, dental or toiletry purposes6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
PatentTitleYear
11,124,760Methods for overcoming glutamine deprivation during mammalian cell culture202110,844,416Manganese supplementation for control of glycosylation in mammalian cell culture process202010,707,486Process for making a cathode active material and a precursor therefore, cathode active material and its use202010,676,772Control of protein glycosylation by culture medium supplementation and cell culture process parameters202010,526,212Mixed transition metal oxides for lithium ion batteries202010,468,678Process for making cathode materials for lithium ion batteries20199,944,968Control of protein glycosylation by culture medium supplementation and cell culture process parameters20189,096,879'Method of supplementing culture media to prevent undesirable amino acid substitutions'20157,666,416'Mammalian cell culture process'20106,656,466'Human tumor necrosis factorimmunoglobulin(TNFR1-IgG1) chimera composition'20036,528,286'Mammalian cell culture process for producing glycoproteins'20035,721,121'Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein'19985,705,364'Mammalian cell culture process'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2010Patents assigned to GENENTECH INC (5)· patent assignee history
1998–2010Based in San Mateo, CA, US· patent location history
2015–2021Patents assigned to BIOGEN MA INC (5)· patent assignee history
2015Patents assigned to CHEN PAUL (1)· patent assignee history
2015–2021Based in Lexington, MA, US· patent location history
2018–2021Patents assigned to SAMSUNG BIOEPIS (3)· patent assignee history
2019–2020Patents assigned to BASF SE (3)· patent assignee history
2019–2020Based in Heddesheim, DE· patent location history
2020Based in Weston, MA, US· patent location history
2020Based in Eppelheim, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN MA INC | 5 | 2015–2021 |
| GENENTECH INC | 5 | 1998–2010 |
| BASF SE | 3 | 2019–2020 |
| SAMSUNG BIOEPIS | 3 | 2018–2021 |
| CHEN PAUL | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Mateo, California, US | 5 | 1998–2010 |
| Lexington, Massachusetts, US | 4 | 2015–2021 |
| Heddesheim, DE | 2 | 2019–2020 |
| Weston, Massachusetts, US | 1 | 2020 |
| Eppelheim, DE | 1 | 2020 |